Autopsy report · NCT06124924

SGLT2 Inhibitors After Acute Kidney Injury With Indications Pilot

“Poor recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 4 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Early Phase 1

Sponsor

University of Minnesota

Sponsor type

University, hospital or other

Conditions

Acute Kidney Injury

Interventions

SGLT2 inhibitor

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Pilot RCT Evaluating a One Stop Vein Clinic
  “Very poor recruitment” (95% match in meaning)
• Prospective Evaluation of Quality of Life in Patients With Acute Colonic Diverticular Disease
  “poor recruitment status” (93% match in meaning)
• Expanding Access to Comprehensive Geriatrics Care Via Telehealth
  “Inadequate recruitment” (92% match in meaning)
• Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer
  “Low recruitment” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.